These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8325604)

  • 21. Chronic administration of propranolol improves vascular contractile responsiveness in portal hypertensive rats.
    Huang YT; Lin HC; Tsai JF; Hou MC; Hong CY
    Eur J Clin Invest; 1997 Jul; 27(7):550-5. PubMed ID: 9263740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
    Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
    Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of cyclic guanosine monophosphate and K+ channels as mediators of the mesenteric vascular hyporesponsiveness in portal hypertensive rats.
    Atucha NM; Ortíz MC; Fortepiani LA; Ruiz FM; Martínez C; García-Estañ J
    Hepatology; 1998 Apr; 27(4):900-5. PubMed ID: 9580129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased angiogenesis in portal hypertensive rats: role of nitric oxide.
    Sumanovski LT; Battegay E; Stumm M; van der Kooij M; Sieber CC
    Hepatology; 1999 Apr; 29(4):1044-9. PubMed ID: 10094944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats.
    Sieber CC; Lee FY; Groszmann RJ
    Hepatology; 1996 May; 23(5):1218-23. PubMed ID: 8621156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic and splanchnic hemodynamics following hemorrhage and volume restitution with Haemaccel in portal hypertensive rats: the effect of propranolol.
    Hilzenrat N; Arish A; Yaari A; Sikuler E
    J Gastroenterol Hepatol; 2001 Jul; 16(7):796-800. PubMed ID: 11446889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
    Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
    Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic effects of chronic tetrandrine and propranolol administration on portal hypertensive rats.
    Huang YT; Liu TB; Lin HC; Yang MC; Hong CY
    Pharmacology; 1997 May; 54(5):225-31. PubMed ID: 9380768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis.
    Heller J; Trebicka J; Shiozawa T; Schepke M; Neef M; Hennenberg M; Sauerbruch T
    Liver Int; 2005 Jun; 25(3):657-66. PubMed ID: 15910503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
    Guo L; Tabrizchi R
    Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats.
    Hori N; Wiest R; Groszmann RJ
    Hepatology; 1998 Dec; 28(6):1467-73. PubMed ID: 9828208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model.
    Kroeger RJ; Groszmann RJ
    Hepatology; 1985; 5(3):425-30. PubMed ID: 3922868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
    Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
    Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro vascular responsiveness to norepinephrine in experimental portal hypertension.
    Bomzon A; Jacob G; Lee SS; Meddings J
    Clin Invest Med; 1991 Feb; 14(1):63-71. PubMed ID: 2040106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxical relationship between the superior cervical ganglia and the antihypertensive action of propranolol in the spontaneous hypertensive rat.
    Tuttle R; Elias B; McCleary M; Endy T
    J Pharmacol Exp Ther; 1982 Dec; 223(3):824-33. PubMed ID: 7143243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
    Heinemann A; Schuligoi R; Lippe IT; Stauber RE
    Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.